Literature DB >> 7070203

High affinity binding sites for gamma-hydroxybutyric acid in rat brain.

J Benavides, J F Rumigny, J J Bourguignon, C Cash, C G Wermuth, P Mandel, G Vincendon, M Maitre.   

Abstract

The existence of a specific synthesizing enzyme for gamma-hydroxybutyric acid in rat brain has recently been reported. Here, for the first time, we demonstrate the presence of a high affinity, apparently specific binding site for this compound in the same tissue. This binding does not require Na+ and takes place optimally at pH 5.5. The bound gamma-hydroxybutyric acid is not displacable by GABA or baclofen. We report here on some structurally related compounds of GHB with a similar or better binding capacity than GHB itself. The number of binding sites increases with age up to adulthood and differs depending on the brain region. In primary tissue cultures of pure chicken neurones and glia, gamma-hydroxybutyric acid binding occurs exclusively in the neuronal preparations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7070203     DOI: 10.1016/0024-3205(82)90624-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  30 in total

1.  GABAB-ergic motor cortex dysfunction in SSADH deficiency.

Authors:  Janine Reis; Leonardo G Cohen; Phillip L Pearl; Brita Fritsch; Nikolai H Jung; Irene Dustin; William H Theodore
Journal:  Neurology       Date:  2012-06-20       Impact factor: 9.910

2.  The GABAB antagonist, CGP 35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis.

Authors:  P C Waldmeier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

3.  Behavioral effects of gamma-hydroxybutyrate, its precursor gamma-butyrolactone, and GABA(B) receptor agonists: time course and differential antagonism by the GABA(B) receptor antagonist 3-aminopropyl(diethoxymethyl)phosphinic acid (CGP35348).

Authors:  Wouter Koek; Susan L Mercer; Andrew Coop; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2009-06-29       Impact factor: 4.030

4.  The GABAB-receptor antagonist, CGP 35348, antagonises gamma-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice.

Authors:  H Nissbrandt; G Engberg
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

5.  Extrasynaptic site of action for γ-hydroxybutyrate.

Authors:  S J Enna
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-31       Impact factor: 11.205

6.  Behavioral effects of gamma-hydroxybutyrate in humans.

Authors:  Alison Oliveto; William Brooks Gentry; Rhonda Pruzinsky; Kishorchandra Gonsai; Thomas R Kosten; Bridget Martell; James Poling
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

Review 7.  Biochemical dissection of the gamma-aminobutyrate synapse.

Authors:  A J Turner; S R Whittle
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

8.  Gamma-Hydroxybutyrate Increases Resting-State Limbic Perfusion and Body and Emotion Awareness in Humans.

Authors:  Oliver G Bosch; Fabrizio Esposito; Michael M Havranek; Dario Dornbierer; Robin von Rotz; Philipp Staempfli; Boris B Quednow; Erich Seifritz
Journal:  Neuropsychopharmacology       Date:  2017-05-31       Impact factor: 7.853

9.  Effects of 1,4-butanediol administration on oxidative stress in rat brain: study of the neurotoxicity of gamma-hydroxybutyric acid in vivo.

Authors:  Angela M Sgaravatti; Alessandra S Magnusson; Amanda S Oliveira; Caroline P Mescka; Fernanda Zanin; Mirian B Sgarbi; Carolina D Pederzolli; Angela T S Wyse; Clóvis M D Wannmacher; Moacir Wajner; Carlos S Dutra-Filho
Journal:  Metab Brain Dis       Date:  2009-03-19       Impact factor: 3.584

Review 10.  Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review.

Authors:  Fabio Caputo; Teo Vignoli; Icro Maremmani; Mauro Bernardi; Giorgio Zoli
Journal:  Int J Environ Res Public Health       Date:  2009-06-24       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.